Showing results (561-570 of 2,425) with videos related to
Sort By:
Pageof 243
Annals of Diagnostic Pathology|December 19, 2023
Intraoperative pathologic diagnosis of central nervous system lymphomas: A comparison of frozen and permanent section diagnoses, and the significance of preoperative imagingAslı Kahraman, Fikret Dirilenoğlu, İsmail Güzeliş, et al.Annals of Diagnostic Pathology|December 1, 2023
SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrumXiaona Yin, Xiaoqun Yang, Suying Wang, et al.Annals of Diagnostic Pathology|November 26, 2023
Granulomatous lobular mastitis co-existing with ductal carcinoma in situ: Report of three cases and review of the literatureJianmin Zhu, Xiuming Miao, Xin Li, et al.Annals of Diagnostic Pathology|March 13, 2024
Expression of CD25, mast cell markers and T-cell markers in eosinophilic esophagitisArkar Htoo, Cary M Qualia, Rose George, et al.Annals of Diagnostic Pathology|February 1, 2024
Comparison of different criteria for estimating major pathological response in resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapyWei Sun, Xinying Liu, Chenglong Wang, et al.Annals of Diagnostic Pathology|May 11, 2024
Primary mucinous tumors of the renal pelvis: Clinical, histopathological, and molecular analysis of three casesHuifang Zhang, Weiqiang Wu, Shanshan Wu, et al.Annals of Diagnostic Pathology|May 29, 2024
Ovarian angiosarcoma: A systematic review of literature and survival analysisShafi Rehman, Arya Harikrishna, Amisha Silwal, et al.Annals of Diagnostic Pathology|October 18, 2023
Xanthogranulomatous inflammation of the female genital tract: An 11-year single institutional study of 40 casesParul Mehrotra, Gayatri RavikumarAnnals of Diagnostic Pathology|October 3, 2024
Orbital masses as a rare presentation of Rosai-Dorfman disease: Clinicopathologic characterization of five casesTyler Steidl, Liping Li, Paul D Langer, et al.Annals of Diagnostic Pathology|November 23, 2024
Recurrence score-predicted value derived from estrogen receptor, tumor-infiltrating lymphocytes, progesterone receptor, and Ki-67 may substitute for the Oncotype DX recurrence score in estrogen receptor (ER)+/human epidermal growth factor receptor 2 (HER2)- breast cancerKeiichi Sotome, Hinako Maeda, Takako Yanagisawa, et al.Pageof 243